BMY vs NXRT · P/E 17, rev $24.46B vs rev $128.2M
Bristol-Myers Squibb Company (BMY) versus Nexpoint Residential Trust Inc (NXRT) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Nexpoint Residential Trust Inc (NXRT) is a reit - residential company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported NXRT revenue for 2026-06-30 was $128.2M. Net income was -$15.4M. NXRT currently screens at market cap $1.50B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. NXRT currently screens at market cap $1.50B.
Not investment advice. Open the BMY and NXRT stock pages for the full models.
Not investment advice.